Search

Your search keyword '"Santucci, Rodrigo"' showing total 84 results

Search Constraints

Start Over You searched for: Author "Santucci, Rodrigo" Remove constraint Author: "Santucci, Rodrigo" Language english Remove constraint Language: english
84 results on '"Santucci, Rodrigo"'

Search Results

7. Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation

17. A baurusuchid yearling (Mesoeucrocodylia, Crocodyliformes), from the Adamantina Formation, Bauru Group, Upper Cretaceous of Brazil.

18. Outcomes of Conservative Indication Criteria for First-Line Treatment in Chronic Lymphocytic Leukemia: Insights from the Brazilian Registry of CLL

20. Lower access to risk stratification tests and drugs, and worse survival of chronic lymphocytic leukaemia patients treated in public as compared to private hospitals in Brazil: A retrospective analysis of the Brazilian registry of chronic lymphocytic leukaemia

22. Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL

23. Retrospective Evaluation of Real-World Treatment Patterns in Patients with Mantle Cell Lymphoma - REALM in a Single Brazilian Center

24. Morphological and compositional analyses of coprolites from the Upper Cretaceous Bauru Group reveal dietary habits of notosuchian fauna.

26. Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene

27. Superiority of Triple Combination Bortezomib + Cyclophosphamide and Dexamethasone (VCD) Versus Thalidomide + Cyclophosphamide and Dexamethasone (CTD) in Newly Diagnosed Multiple Myeloma Transplant-Eligible Patients

32. Lymphoma Symptoms: Data from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL) Treated with Ibrutinib Vs. Temsirolimus

33. Ibrutinib Vs Temsirolimus: Results from a Phase 3, International, Randomized, Open-Label, Multicenter Study in Patients with Previously Treated Mantle Cell Lymphoma (MCL)

38. Genomic Profile of Patients with Triple Negative (JAK2, CALR and MPL) Essential Thrombocythemia and Primary Myelofibrosis

39. The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia

40. Whole Exome Sequencing of Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders (MDS/MPD)

41. Incidence and Impact of Activating Mutations of the RAS-RAF-MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders–Unclassified (MDS/MPD-U)

47. Crocodylomorph eggs and eggshells from the Adamantina Formation (Bauru Group), Upper Cretaceous of Brazil.

49. First titanosaur (Saurischia, Sauropoda) axial remains from the Uberaba Formation, Upper Cretaceous, Bauru Group, Brazil.

50. A NEW TITANOSAUR FROM WESTERN SÃO PAULO STATE, UPPER CRETACEOUS BAURU GROUP, SOUTH-EAST BRAZIL.

Catalog

Books, media, physical & digital resources